LIGAND PHARMACEUTICALS INC — Director's Dealing 2017

Nov 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2017-11-16

Reporting Person: KOZARICH JOHN W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-16	Common Stock	S	5000	$141.71	Disposed	35649	Direct

Footnotes

F1: The reporting person contributed LGND common stock to an exchange fund in exchange for shares of the exchange fund. The LGND common stock was valued at $141.71 per share for the purpose of determining the number of shares of the exchange fund issuable to the reporting person.